XT is among the early investors in Israeli startups. Focusing on early-growth companies with the potential to become market frontrunners, XT leverages its strong, experienced team to drive success. To date, XT has invested in 100 companies, resulting in exits and category leaders such as Duve, Checkmarx, Lumenis, Enzymotec, Cymbio, Sofwave, and Phytech.